Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Cepharanthine could be a strong antiviral against COVID-19.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Certain drugs that block specific enzymes can help treat prostate diseases.

A drug called cimetidine can help treat hair loss in women by blocking androgen receptors. However, it's not the first choice and needs more research.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Ritlecitinib works well and is safe for treating alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Fexofenadine may help treat a difficult type of hair loss.

An oil-in-water emulsion with CBD and ginger root extract significantly improved symptoms of dry and eczema-prone skin.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.